Democratic lawmakers are playing a dangerous game with the lives of seniors as they pursue drug pricing schemes that would put dozens of future medicines out of reach.

A new study from the nonpartisan Congressional Budget Office has found that setting price controls on drugs, as legislators are trying to do in their budget reconciliation bill, could dramatically reduce the number of new medications developed, approved, and brought to market.